1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
THC Biomed Intl Ltd.

THC Biomed Intl Ltd.

THCBF
THC Biomed Intl Ltd.US flagOther OTC
0.00
USD
- -
- -
205,015.00Market Cap
THC Biomed Intl Ltd.
THCBF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.03
0.02
0.02
0.02
Revenue per Share
-0.15
-0.08
-0.43
-0.07
-0.19
-0.05
- -
-0.08
-0.08
-0.01
-0.01
-0.11
-0.1
- -
-0.04
-0.02
-0.02
Basic EPS, GAAP
-0.11
-0.04
-0.05
-0.1
-0.01
-0.06
-0.01
-0.04
-0.02
-0.01
-0.03
-0.07
-0.07
-0.01
-0.01
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.82
-1.7
-1.67
-0.53
-0.59
-3.09
-0.01
-1.38
-0.08
- -
0.01
0.03
0.01
0.02
0.01
0.04
0.03
Book Value per Share
0.68
0.54
0.04
0.24
-0.01
-0.07
- -
- -
-0.04
- -
0.02
0.11
0.1
0.1
0.06
0.04
0.03
Tangible Book Value per Share
6
6
9
32
43
7
48
17
41
89
102
112
133
156
164
164
164
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
4
4
3
3
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,425.05
-260.49
-318.44
4.91
-157.25
-95.89
-106.7
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Depreciation Expense
-1
-1
-4
-2
-8
- -
- -
-1
-3
-1
-1
-12
-13
- -
-6
-3
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,010.2
-1,346.42
-852.53
-3.87
-168.49
-91.79
-128.44
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
-4
7
2
2
-2
-3
-5
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
1
1
2
1
1
LT Debt
4
4
- -
8
- -
- -
- -
- -
-2
- -
2
12
13
15
10
7
5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-119.74
-593.12
-506.45
-5.83
-262.78
-82.68
-177.94
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'23
Jan'23
Apr'23
ST Debt
4
4
4
LT Borrowings
- -
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
169
169
169
Market Capitalization
5
5
9

Working Capital

FRC

•

in mil. unless spec.
Oct'23
Jan'23
Apr'23
Total Current Assets
4
4
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
3
3
3
Total Current Liabilities
7
8
8
Payables & Accruals
3
4
4
ST Debt
4
4
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
334.81%
94.89%
-29.13%
Free Cash Flow
47.3%
27.95%
43.76%
Net Income, GAAP
617.92%
1,129.32%
-51.79%
Sales/Revenue/Turnover
- -
333.14%
-11.51%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
1
1
1
4
2022
1
1
1
1
3
2023
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
-0.02
-0.01
- -
-0.04
2022
- -
-0.01
- -
- -
-0.02
2023
- -
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
H. Lundbeck A/S (HLBBF)
Vita Life Sciences Limited (VLS.AX)
Tibet AIM Pharm. Inc. (002826.SZ)
Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
Imagenetix, Inc. (IAGX)
Bajaj Healthcare Ltd (BAJAJHCARE.NS)
Business
THC Biomed Intl Ltd. operates as a federally licensed Canadian producer and supplier of cannabis, serving both medical and adult-use markets. The company cultivates a variety of organically grown dried flower and offers a comprehensive product lineup, including its "THC KISS" brand cannabis beverage shots, gummies, and biscuits, alongside pre-rolls and pure cannabis sticks. Additionally, it provides cannabis genetics and seeds for cultivators and supports micro-producers with cultivation services. Established in 2012, the company maintains its headquarters in Kelowna, British Columbia, while also pursuing strategic international market opportunities.